Items Tagged ‘IP’

September 28th, 2015

Intraperitoneal Chemotherapy Underused in Ovarian Cancer


The use of intraperitoneal (IP) chemotherapy appears to be utilized in fewer than 50% of clinical practices, despite results indicating improved survival with its use in certain patients with ovarian cancer. These results were recently published in the Journal of Clinical Oncology. IP chemotherapy refers to chemotherapy that is delivered directly into the pelvis/abdominal area, […]

View full entry

Tags: intraperitoneal chemotherapy, IP, IV chemotherapy, News, Ovarian Cancer, Stage I Ovarian Cancer, Stage II-IV Ovarian Cancer